Summary
Rising drug costs strain NHS budgets, yet many new medicines deliver fewer health benefits than alternative interventions. A Lancet study underscores the need to reassess spending priorities and tackle inefficiencies in resource allocation for better patient outcomes, writes Steve Black in this HSJ article.
The mythbuster: Buying ‘innovative’ drugs is not the best use of NHS funds (HSJ, 23 December 2024)
https://www.hsj.co.uk/daily-insight/the-mythbuster-buying-innovative-drugs-is-not-the-best-use-of-nhs-funds/7038403.article
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now